Publications

Verny, C., Bachoud-Levi, A., Durr, A., Goizet, C., Azulay, J., Simonin, C., Tranchant, C., Calvas, F., Krystkowiak, P., Charles, P., Youssov, K., Scherer, C., Prundean, A., Olivier, A., Reynier, P., Saudou, F., Maison, P., Allain, P., Von Studnitz, E., Bonneau, D. & Cyst-Hd Study, G. (2017). A randomized, double-blind, placebo-controlled trial evaluating cysteamine in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 32(6), 932-936. doi:10.1002/mds.27010

Van Der Gucht, A., Aoun Sebaiti, M., Guedj, E., Aouizerate, J., Yara, S., Gherardi, R., Evangelista, E., Chalaye, J., Cottereau, A., Verger, A., Bachoud-Levi, A., Abulizi, M., Itti, E. & Authier, F. (2017). Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 58(3), 492-498. doi:10.2967/jnumed.114.151878

Van Der Gucht, A., Aoun-Sebaiti, M., Kauv, P., Guedj, E., Aouizerate, J., Verger, A., Gherardi, R., Bachoud-Levi, A., Authier, F. & Itti, E. (2016). FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis. Nuclear medicine and molecular imaging, 50(1), 80-4. doi:10.1007/s13139-015-0371-z

Schramm, C., Vial, C., Bachoud-Levi, A. & Katsahian, S. (2015). Clustering of longitudinal data by using an extended baseline: A new method for treatment efficacy clustering in longitudinal data. Statistical methods in medical research, 27(1), 97-113. doi:10.1177/0962280215621591

Désaméricq, G., Youssov, K., Charles, P., Saleh, N., Olivier, A., Sherer-Gagou, C. & Verny, C. (2016). Guidelines for clinical pharmacological practices in Huntington's disease. Rev Neurol (Paris), 172(8-9), 423-432. doi:10.1016/j.neurol.2016.07.012

Cubo, E., Ramos-Arroyo, M., Martinez-Horta, S., Martínez-Descalls, A., Calvo, S., Gil-Polo, C. & European Hd, N. (2016). Clinical manifestations of intermediate allele carriers in Huntington disease. Neurology, 87(6), 571-8. doi:10.1212/WNL.0000000000002944

De Diego-Balaguer, R., Rodríguez-Fornells, A. & Bachoud-Levi, A. (2015). Prosodic cues enhance rule learning by changing speech segmentation mechanisms. Frontiers in psychology, 6, 1478. doi:10.3389/fpsyg.2015.01478

Simonin, C., Duru, C., Salleron, J., Hincker, P., Charles, P., Delval, A., Youssov, K., Burnouf, S., Azulay, J., Verny, C., Scherer, C., Tranchant, C., Goizet, C., Debruxelles, S., Defebvre, L., Sablonnière, B., Romon-Rousseaux, M., Buée, L., Destée, A., Godefroy, O., Durr, A., Landwehrmeyer, B., Registry Study Of The European Huntington'S Disease, N., Bachoud-Levi, A., Richard, F., Blum, D., Krystkowiak, P. & Huntington French Speaking, N. (2013). Association between caffeine intake and age at onset in Huntington's disease. Neurobiology of disease, 58, 179-82. doi:10.1016/j.nbd.2013.05.013

Bartolomeo, P., Bachoud-Levi, A. & De Schotten, T. (2014). The anatomy of cerebral achromatopsia: a reappraisal and comparison of two case reports. Cortex, 56, 138-44. doi:10.1016/j.cortex.2013.01.013

Dulin, D., Cavezian, C., Serrière, C., Bachoud-Levi, A., Bartolomeo, P. & Chokron, S. (2011). Colour, face, and visuospatial imagery abilities in low-vision individuals with visual field deficits. Quarterly journal of experimental psychology (2006), 64(10), 1955-70. doi:10.1080/17470218.2011.608852

Bachoud-Levi, A. (2009). Neural grafts in Huntington's disease: viability after 10 years. The Lancet. Neurology, 8(11), 979-81. doi:10.1016/S1474-4422(09)70278-9

Lefaucheur, J., Ménard-Lefaucheur, I., Maison, P., Baudic, S., Cesaro, P., Peschanski, M. & Bachoud-Levi, A. (2006). Electrophysiological deterioration over time in patients with Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 21(9), 1350-4. doi:10.1002/mds.20966

Cohen, L. & Bachoud-Levi, A. (1995). The Role of the Output Phonological Buffer in the Control of Speech Timing: A Single Case Study. Cortex, 31(3), 469-486. doi:10.1016/S0010-9452(13)80060-3

Bartolomeo, P., Bachoud-Levi, A. & Denes, G. (1997). Preserved imagery for colours in a patient with cerebral achromatopsia. Cortex, 33(2), 369-378. doi:10.1016/S0010-9452(08)70012-1

Degos, J., Bachoud-Levi, A., Ergis, A., Petrissans, J. & Cesaro, P. (1997). Selective inability to point to extrapersonal targets after left posterior parietal lesions: An objectivization disorder? Neurocase, 3(1), 31-39. doi:10.1093/neucas/3.1.31

Barba, G., Boissé, M., Bartolomeo, P. & Bachoud-Levi, A. (1997). Confabulation following rupture of posterior communicating artery. Cortex, 33(3), 563-570. doi:10.1016/S0010-9452(08)70237-5

Bartolomeo, P., Dalla Barba , G., Boissé, M., Bachoud-Levi, A., Degos, J. & Boller, F. (1998). Right-side neglect in Alzheimer's disease. Neurology, 51(4), 1207-1209. doi:10.1212/WNL.51.4.1207

Bartolomeo, P., Bachoud-Levi, A., De Gelder, B., Denes, G., Barba, G., Brugières, P. & Degos, J. (1998). Multiple-domain dissociation between impaired visual perception and preserved mental imagery in a patient with bilateral extrastriate lesions. Neuropsychologia, 36(3), 239-249. doi:10.1016/S0028-3932(97)00103-6

De Gelder, B., Bachoud-Levi, A. & Degos, J. (1998). Inversion superiority in visual agnosia may be common to a variety of orientation polarised objects besides faces. Vision Research, 38(18), 2855-2861. doi:10.1016/S0042-6989(97)00458-6

Bartolomeo, P., Bachoud-Levi, A., Degos, J. & Boiler, F. (1998). Disruption of residual reading capacity in a pure alexic patient after a mirror-image right-hemispheric lesion. Neurology, 50(1), 286-288. doi:10.1212/WNL.50.1.286

Domigo, V., Authier, F., Bachoud-Levi, A., Gherardi, R. & Degos, J. (1999). Should hepatitis B vaccine be contra-indicated in myasthenia gravis? Autoimmunity. doi:10.3109/08916939908995383

Dalla Barba , G., Bartolomeo, P., Ergis, A., Boissé, M. & Bachoud-Levi, A. (1999). Awareness of anosognosia following head trauma. Neurocase, 5(1), 59-67. doi:10.1093/neucas/5.1.59

Peterson, M., De Gelder, B., Rapcsak, S., Gerhardstein, P. & Bachoud-Levi, A. (2000). Object memory effects on figure assignment: conscious object recognition is not necessary or sufficient. Vision Research, 40, 1549-1567. doi:10.1016/S0042-6989(00)00053-5

Cochen, V., Degos, J. & Bachoud-Levi, A. (2000). Efficiency of carbamazepine in the treatment of micturitional disturbances in Huntington disease. Neurology. doi:10.1212/wnl.55.12.1934

Bachoud-Levi, A., Bourdet, C., Brugières, P., Nguyen, J., Grandmougin , T., Haddad , B., Jény , R., Bartolomeo, P., Boissé, M., Barba, G., Degos, J., Ergis, A., Lefaucheur, J., Lisovoski , F., Pailhous , E., Remy, P., Palfi, S., Defer, G., Cesaro, P., Hantraye, P. & Peschanski, M. (2000). Safety and tolerability assessment of intrastriatal neural allografts in five patients with Huntington's disease. Experimental Neurology, 161(1), 194-202. doi:10.1006/exnr.1999.7239

Bachoud-Levi, A., Ergis, A., Cesaro, P. & Degos, J. (2000). Dissociation between distal and proximal left limb agraphia and agraphesthesia in a patient with a callosal disconnection syndrome. Cortex, 36(3), 351-363. doi:10.1016/S0010-9452(08)70846-3

De Gelder, B., Pourtois, G., Vroomen, J. & Bachoud-Levi, A. (2000). Covert processing of faces in prosopagnosia is restricted to facial expressions: Evidence from cross-modal bias. Brain and Cognition, 44(3), 425-444. doi:10.1006/brcg.1999.1203

Callaghan, J., Stopford, C., Arran, N., Boissé, M., Coleman, A., Santos, R., Dumas, E., Hart, E., Justo, D., Owen, G., Read, J., Say, M., Durr, A., Leavitt, B., Roos, R., Tabrizi, S., Bachoud-Levi, A., Bourdet, C., Van Duijn, E. & Craufurd, D. (2015). Reliability and factor structure of the short problem behaviors assessment for huntington’s disease (PBA-s) in the TRACK-HD and REGISTRY studies. Journal of Neuropsychiatry and Clinical Neurosciences, 27(1), 59-64. doi:10.1176/appi.neuropsych.13070169

Bachoud-Levi, A. & Perrier, A. (2014). Regenerative medicine in Huntington's disease: Current status on fetal grafts and prospects for the use of pluripotent stem cell. Revue Neurologique, 170(12), 749-762. doi:10.1016/j.neurol.2014.10.007

Vittori, A., Orth, M., Roos, R., Outeiro, T., Giorgini, F., Hollox, E., Bachoud-Levi, A. & Registry Investigators Of The European Huntington’s Disease, N. (2013). β-defensin genomic copy number does not influence the age of onset in huntington’s disease. Journal of Huntington's Disease, 2(1), 107-124. doi:10.3233/JHD-130047